Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
236 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (1)
  • Closed (2)

Medical Condition

  • Show all (299)
  • Addiction (4)
  • Autoimmune Disorders (1)
  • Blood Disorders (1)
  • Cancer (27)
    • Brain Cancer (12)
    • Breast Cancer (1)
    • (-) Leukemia (2)
    • Lung Cancer (3)
    • Lymphoma (1)
    • Skin Cancer (1)
  • COVID-19 (Coronavirus) (1)
  • Ear, Nose and Throat (3)
  • Endocrine & Metabolic Disease (1)
  • Eye (1)
  • Healthy Volunteers (42)
  • Heart Disease (1)
  • Infectious Disease (2)
  • Neurological Disorders (165)
  • Obesity (1)
  • Obstetrics & Gynecology (3)
  • Pediatrics (10)
  • Psychiatric Disorders (31)
  • (-) Rehabilitation (1)
    • Cerebral Palsy (1)
  • Stroke (1)
  • Transplant (2)
  • Vascular Conditions (1)
Displaying 1 - 3 of 3

Spinal Cord Associative Plasticity in Cerebral Palsy (SCAP-CP)

Condition: Rehabilitation / Cerebral Palsy
Investigator: Jason Carmel, MD, PhD
Status: Currently Recruiting
The goal of this research is to combine non-invasive brain and sensory nerve stimulation to investigate their influence on hand function. Many adults with hemiplegic CP no longer actively receive therapies but have further hand goals they want to achieve. The information we learn from this study may help us learn how to design…
Read More

A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy

Condition: Cancer / Leukemia
Investigator: Ran Reshef, MD
Status: Closed
Patients who will be receiving immune effector cell (IEC) therapy for the treatment of their cancer (leukemia) are being asked to participate in this study. IEC can produce a harmful side effect called Cytokine Release Syndrome (CRS). CRS involves a release of a large amount of proteins into the bloodstream. This may cause changes in blood pressure and…
Read More

A study of adding study drug Sorafenib to the usual treatment in children and teens with AML (Acute Myeloid Leukemia)

Condition: Cancer / Leukemia
Investigator: Alice Lee, MD
Status: Closed
This study is for children and teens who have been diagnosed with Acute Myeloid Leukemia (AML). AML is a cancer of the bone marrow, the spongy tissue inside the large bones of the body where blood cells are made. In AML, the bone marrow makes large numbers of immature white blood cells called blasts. These blast cells crowd out the normal cells of the bone…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science